Your President isn’t going to do anything about drug prices, not domestically and not internationally. Neither will Europe or Asia pay more for medicine. Innovation in medicine does NOT depend on unlimited price gouging–that’s a lazy lie by PhRMA to protect their clients’ profits. Pharma companies can be profitable with price controls and should be competing on EFFICACY and not on marketing.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology